Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoko Yamamoto

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Molecular Therapy. Methods & Clinical Development|April 18, 2020
Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early GenesSeiji Kuroda, Yoshitaka Miyagawa, Yuriko Sato, et al.
Molecular Therapy. Methods & Clinical Development|September 22, 2025
Durable tissue-specific transgene expression in newborn mice following intraperitoneal delivery of non-cytotoxic HSV vectorsYoshitaka Miyagawa, Motoyo Maruyama, Atsushi Sakai, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Molecular Therapy. Methods & Clinical Development|April 18, 2020
Protocol Optimization for the Production of the Non-Cytotoxic JΔNI5 HSV Vector Deficient in Expression of Immediately Early GenesSeiji Kuroda, Yoshitaka Miyagawa, Yuriko Sato, et al.
Molecular Therapy. Methods & Clinical Development|September 22, 2025
Durable tissue-specific transgene expression in newborn mice following intraperitoneal delivery of non-cytotoxic HSV vectorsYoshitaka Miyagawa, Motoyo Maruyama, Atsushi Sakai, et al.
Pageof 2